293
Views
68
CrossRef citations to date
0
Altmetric
Review

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast

, &
Pages 201-210 | Published online: 27 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Yael Renert-Yuval & Emma Guttman-Yassky. (2016) A novel therapeutic paradigm for patients with extensive alopecia areata. Expert Opinion on Biological Therapy 16:8, pages 1005-1014.
Read now
Xiaoyu Qu, Sixi Zhang, Lina Tao & Yanqing Song. (2016) A meta-analysis of apremilast on psoriatic arthritis long-term assessment of clinical efficacy (PALACE). Expert Review of Clinical Pharmacology 9:6, pages 799-805.
Read now
Mindi S Miller. (2015) Phosphodiesterase inhibition in the treatment of autoimmune and inflammatory diseases: current status and potential. Journal of Receptor, Ligand and Channel Research 8, pages 19-30.
Read now
Małgorzata Mazur, Jacek Karczewski, Martha Lodyga, Ryszard Żaba & Zygmunt Adamski. (2015) Inhibitors of phosphodiesterase 4 (PDE 4): A new therapeutic option in the treatment of psoriasis vulgaris and psoriatic arthritis. Journal of Dermatological Treatment 26:4, pages 326-328.
Read now
Arash Taheri, Laura F Sandoval, Sara Moradi Tuchayi, Hossein Alinia, Parisa Mansoori & Steven R Feldman. (2014) Emerging treatment options for psoriasis. Psoriasis: Targets and Therapy 4, pages 27-35.
Read now
Alberto Cauli, Giovanni Porru, Matteo Piga, Alessandra Vacca, Grazia Dessole & Alessandro Mathieu. (2014) Clinical potential of apremilast in the treatment of psoriatic arthritis. ImmunoTargets and Therapy 3, pages 91-96.
Read now
Uwe Pleyer & Nicole Stübiger. (2014) New pharmacotherapy options for noninfectious posterior uveitis. Expert Opinion on Biological Therapy 14:12, pages 1783-1799.
Read now
Barry J Sheane & Vinod Chandran. (2014) Investigational drugs for treating psoriatic arthritis. Expert Opinion on Investigational Drugs 23:7, pages 1001-1016.
Read now
Sowmya Varada, Suzanne J Tintle & Alice B Gottlieb. (2014) Apremilast for the treatment of psoriatic arthritis. Expert Review of Clinical Pharmacology 7:3, pages 239-250.
Read now
Maeve Lynch, Brian Kirby & Richard B Warren. (2014) Treating moderate to severe psoriasis – best use of biologics. Expert Review of Clinical Immunology 10:2, pages 269-279.
Read now

Articles from other publishers (58)

Manoj Arra, Gaurav Swarnkar, Naga Suresh Adapala, Syeda Kanwal Naqvi, Lei Cai, Muhammad Farooq Rai, Srikanth Singamaneni, Gabriel Mbalaviele, Robert Brophy & Yousef Abu-Amer. (2022) Glutamine metabolism modulates chondrocyte inflammatory response. eLife 11.
Crossref
April W. Armstrong, Dhaval Patil, Eugenia Levi, Catherine B. McGuiness, Xin Wang, Yi Wang, Chi-Chang Chen, Elizabeth Nguyen & Paul S. Yamauchi. (2021) Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records. Dermatology and Therapy 11:5, pages 1733-1749.
Crossref
Anupriya Kapoor, Nikunj sethi & Navneet Verma. (2021) Acitretin Loaded Nanocarrier Gel: Formulation and Exploration of In-vitro Release Kinetics . Current Nanomedicine 11:2, pages 102-111.
Crossref
Hong Wang, Yangchun Xu, Meishan Jin, Hongxia Li & Shanshan Li. (2021) miR-383 reduces keratinocyte proliferation and induces the apoptosis in psoriasis via disruption of LCN2-dependent JAK/STAT pathway activation. International Immunopharmacology 96, pages 107587.
Crossref
Xiaoxu Wang, Yafan Li, Lingjun Wu, Shiju Xiao, Yunrun Ji, Yong Tan, Chunyan Jiang & Guangzhong Zhang. (2021) Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression. Biomedicine & Pharmacotherapy 137, pages 111065.
Crossref
Mingyue Cui, Christian Wiraja, Sharon Wan Ting Chew & Chenjie Xu. (2020) Nanodelivery Systems for Topical Management of Skin Disorders. Molecular Pharmaceutics 18:2, pages 491-505.
Crossref
Rui Zhang, Heng Li, Xianglei Zhang, Jian Li, Haixia Su, Qiukai Lu, Guangyu Dong, Huixia Dou, Chen Fan, Zhanni Gu, Qianwen Mu, Wei Tang, Yechun Xu & Hong Liu. (2021) Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment. European Journal of Medicinal Chemistry 211, pages 113004.
Crossref
Shahzaib Maqbool, Arham Ihtesham, Muhammad Nadeem Langove, Sara Jamal, Tabdar Jamal & Hafiz Abu Safian. (2021) Neuro-dermatological association between psoriasis and depression: an immune-mediated inflammatory process validating skin-brain axis theory. AIMS Neuroscience 8:3, pages 340-354.
Crossref
Vivek P. Chavda, Hitesh Prajapati, Punit Zadafiya & Moinuddin Soniwala. 2021. Probiotic Research in Therapeutics. Probiotic Research in Therapeutics 251 271 .
Christian Wiraja, Xiaoyu Ning, Mingyue Cui & Chenjie Xu. (2020) Hydrogel-Based Technologies for the Diagnosis of Skin Pathology. Technologies 8:3, pages 47.
Crossref
Faryal Mustansir Sahi, Ayesha Masood, Nuaman A Danawar, Andrew Mekaiel & Bilal Haider Malik. (2020) Association Between Psoriasis and Depression: A Traditional Review. Cureus.
Crossref
Kumari Padma, SagarSubhash Nanaware, Aruna Yadiyal & PJohn Mathai. (2020) Cognitive impairment in patients with psoriasis: A clinical study in teaching hospital. Journal of Family Medicine and Primary Care 9:8, pages 4001.
Crossref
Alyaa Farid, Aya Tawfik, Basil Elsioufy & Gehan Safwat. (2020) Narrow band ultraviolet B therapy deactivates Th1/Th17 pathway and activates Th2 cytokines secretion in Egyptian psoriatic arthritis patients. Journal of Radiation Research and Applied Sciences 13:1, pages 356-361.
Crossref
Seda Sabah -Özcan & Gülhan Gürel. (2019) The polymorphism rs4696480 in the TLR2 gene is associated with psoriasis patients in the Turkish population. Immunology Letters 211, pages 28-32.
Crossref
Cheng-Yu Lin, Ching-Yun Hsu, Ahmed O. Elzoghby, Ahmed Alalaiwe, Tsong-Long Hwang & Jia-You Fang. (2019) Oleic acid as the active agent and lipid matrix in cilomilast-loaded nanocarriers to assist PDE4 inhibition of activated neutrophils for mitigating psoriasis-like lesions. Acta Biomaterialia 90, pages 350-361.
Crossref
I. M. Marusenko, N. N. Vezikova, S. N. Kondrichin & N. D. Silvestrov. (2019) Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis. Rheumatology Science and Practice 57:1, pages 111-115.
Crossref
Steven R Feldman, Corey L Pelletier, Kathleen L Wilson, Rina K Mehta, Matthew A Brouillette, David Smith & Machaon M Bonafede. (2019) Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics. Journal of Comparative Effectiveness Research 8:1, pages 45-54.
Crossref
Wei Ba, Yuanyuan Xu, Guang Yin, Jingrun Yang, Rui Wang, Sumin Chi, Yinyin Wang & Chengxin Li. (2019) Metformin inhibits pro-inflammatory responses via targeting nuclear factor-κB in HaCaT cells. Cell Biochemistry and Function 37:1, pages 4-10.
Crossref
Heng Li, Jianping Zuo & Wei Tang. (2018) Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases. Frontiers in Pharmacology 9.
Crossref
Yanjie Fu, Xiuyan Li, Yuanzheng Chen, Rongpeng Liu, Renheng Wang & Nan Bai. (2018) Association of ERAP1 gene polymorphisms with the susceptibility to psoriasis vulgaris. Medicine 97:41, pages e12828.
Crossref
Shadi Behfar, Gholamhossein Hassanshahi, Alireza Nazari & Hossein Khorramdelazad. (2018) A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis. Cytokine 110, pages 226-231.
Crossref
Daniyal Aleem & Hassaan Tohid. (2018) Pro-inflammatory Cytokines, Biomarkers, Genetics and the Immune System: A Mechanistic Approach of Depression and Psoriasis. Revista Colombiana de Psiquiatría (English ed.) 47:3, pages 177-186.
Crossref
Daniyal Aleem & Hassaan Tohid. (2018) Pro-inflammatory Cytokines, Biomarkers, Genetics and the Immune System: A Mechanistic Approach of Depression and Psoriasis. Revista Colombiana de Psiquiatría 47:3, pages 177-186.
Crossref
Xuemei Liu, Rui Chen, Guanghuai Zeng, Ying Gao, Xiuping Liu, Donglei Zhang, Pei Hu, Hongyun Wang & Ji Jiang. (2018) Determination of a PDE4 inhibitor Hemay005 in human plasma and urine by UPLC–MS/MS and its application to a PK study. Bioanalysis 10:11, pages 863-875.
Crossref
Liu Liu, Shunping Li, Yue Zhao, Jianglin Zhang & Gang Chen. (2018) Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China. Quality of Life Research 27:5, pages 1323-1333.
Crossref
Fernando Valenzuela, Javier Fernández & Pablo Santa María. (2018) Update on Oral Therapy for Psoriasis. Current Dermatology Reports 7:1, pages 52-58.
Crossref
Yong Jun LeeIn Kee HongHill KimSeong Il HeoDong-Joo KwonWon Gyeong AhnYoung Han KimEun-Jung SeoSang In HanHyun-Jong ChoSun Young KimHeejung Yang. (2018) The Amelioration Effect of the Ethanolic Extract of Cnidium officinale in Mice with Imiquimod-induced Psoriasis-like Skin Lesion . Natural Product Sciences 24:1, pages 21.
Crossref
Yael Renert-Yuval & Emma Guttman-Yassky. (2017) Systemic therapies in atopic dermatitis: The pipeline. Clinics in Dermatology 35:4, pages 387-397.
Crossref
Yael Renert-Yuval & Emma Guttman-Yassky. (2017) The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm. Advances in Therapy 34:7, pages 1594-1609.
Crossref
Ilaria Ruffilli, Francesca Ragusa, Salvatore Benvenga, Roberto Vita, Alessandro Antonelli, Poupak Fallahi & Silvia Martina Ferrari. (2017) Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity. Frontiers in Endocrinology 8.
Crossref
Klaus Rose & Rudolf Happle. (2017) The Effect of Regulation on Pediatric Psoriasis Drug Approvals: The Challenge of the European Union Pediatric Investigation Plans. Pediatric Dermatology 34:3, pages e154-e159.
Crossref
Aditya K. Gupta, Jessie Carviel & William Abramovits. (2016) Treating Alopecia Areata: Current Practices Versus New Directions. American Journal of Clinical Dermatology 18:1, pages 67-75.
Crossref
Tae-Hoon Shin, Hyung-Sik Kim, Soon Choi & Kyung-Sun Kang. (2017) Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action. International Journal of Molecular Sciences 18:2, pages 244.
Crossref
Vibeke Strand, Elaine Husni, Jenny Griffith, Zheng-Yi Zhou, James Signorovitch & Arijit Ganguli. (2016) Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US. Rheumatology and Therapy 3:2, pages 305-322.
Crossref
Natalia V Zamora, Ignacio-Alfredo Valerio-Morales, Maria Angeles Lopez-Olivo, Xin Pan & Maria E Suarez-Almazor. (2016) Phosphodiesterase 4 inhibitors for psoriatic arthritis. Cochrane Database of Systematic Reviews.
Crossref
Fu-Jun Tian, Ying-Ying Zhang, Li-Qian Liu, Ying Xiong, Zong-Shan Wang & Shou-Zhong Wang. (2016) Haptoglobin protein and mRNA expression in psoriasis and its clinical significance. Molecular Medicine Reports 14:4, pages 3735-3742.
Crossref
Lian-guo Chen, Zhe Wang, Shujun Wang, Tao Li, Yongyang Pan & Xixi Lai. (2016) Determination of Apremilast in Rat Plasma by UPLC–MS-MS and Its Application to a Pharmacokinetic Study. Journal of Chromatographic Science 54:8, pages 1336-1340.
Crossref
Neha Arora, Kavita Shah & Shashi Pandey-Rai. (2015) Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants. Protoplasma 253:2, pages 503-515.
Crossref
S. V. Smirnova, M. V. Smolnikova & A. A. Barilo. (2016) Clinical and anamnestic criteria of the progression of psoriasis. Klinicheskaya dermatologiya i venerologiya 15:2, pages 9.
Crossref
Hassaan Tohid, Daniyal Aleem & Chantal Jackson. (2016) Major Depression and Psoriasis: A Psychodermatological Phenomenon. Skin Pharmacology and Physiology 29:4, pages 220-230.
Crossref
Garry G. Graham & Kevin D. Pile. 2016. Compendium of Inflammatory Diseases. Compendium of Inflammatory Diseases 1079 1084 .
Carl Orr & Douglas James Veale. (2015) Therapeutic targets in psoriatic arthritis. International Journal of Clinical Rheumatology 10:6, pages 489-499.
Crossref
Marieke Mohr, Kurt S. Zänker & Thomas Dittmar. (2015) Cancer (stem) cell differentiation: An inherent or acquired property?. Medical Hypotheses 85:6, pages 1012-1018.
Crossref
T. Lotti. (2015) Erfolgreiche Kombinationsbehandlung der Psoriasis mit Phototherapie und niedrig dosierten ZytokinenSuccessful combination treatment for psoriasis with phototherapy and low-dose cytokines. Der Hautarzt 66:11, pages 849-854.
Crossref
. (2015) ▼ Apremilast for psoriasis and psoriatic arthritis. Drug and Therapeutics Bulletin 53:9, pages 105-108.
Crossref
Silvia Martina Ferrari, Ilaria Ruffilli, Michele Colaci, Alessandro Antonelli, Clodoveo Ferri & Poupak Fallahi. (2015) CXCL10 in psoriasis. Advances in Medical Sciences 60:2, pages 349-354.
Crossref
Tiago Torres & Paulo Filipe. (2015) Small Molecules in the Treatment of Psoriasis. Drug Development Research 76:5, pages 215-227.
Crossref
Eun Jin Kang & Arthur Kavanaugh. (2015) Psoriatic arthritis: latest treatments and their place in therapy. Therapeutic Advances in Chronic Disease 6:4, pages 194-203.
Crossref
Kay McNamee, Richard Williams & Michael Seed. (2015) Animal models of rheumatoid arthritis: How informative are they?. European Journal of Pharmacology 759, pages 278-286.
Crossref
Irina Ushach, Amanda M. Burkhardt, Cynthia Martinez, Peter A. Hevezi, Peter Arne Gerber, Bettina Alexandra Buhren, Holger Schrumpf, Ricardo Valle-Rios, Monica I. Vazquez, Bernhard Homey & Albert Zlotnik. (2015) METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages. Clinical Immunology 156:2, pages 119-127.
Crossref
Garry G. Graham & Kevin D. Pile. 2016. Encyclopedia of Inflammatory Diseases. Encyclopedia of Inflammatory Diseases 1 6 .
Carlo Selmi, Elena Generali, Marco Massarotti, Gerolamo Bianchi & Carlo A. Sciré. (2014) New treatments for inflammatory rheumatic disease. Immunologic Research 60:2-3, pages 277-288.
Crossref
Ana Susunaga-Notario, Salud Pérez-Gutiérrez, Miguel Zavala-Sánchez, Julio Almanza-Pérez, Atilano Gutiérrez-Carrillo, Daniel Arrieta-Báez, Ana López-López, Rubén Román-Ramos, José Flores-Sáenz & Francisco Alarcón-Aguilar. (2014) Bioassay-Guided Chemical Study of the Anti-Inflammatory Effect of Senna villosa (Miller) H.S. Irwin & Barneby (Leguminosae) in TPA-Induced Ear Edema. Molecules 19:7, pages 10261-10278.
Crossref
Sowmya Varada. (2018) Abatacept in Psoriatic Arthritis: A Review. Psoriasis Forum 20a:2, pages 60-65.
Crossref
Vincenzo Bruner, Mariangela Atteno, Angelo Spanò, Raffaele Scarpa & Rosario Peluso. (2014) Biological therapies for spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease 6:3, pages 92-101.
Crossref
Medhi Moezzi, Andrea Ferencz & Dénes Lőrinczy. (2013) Evaluation of blood plasma changes by differential scanning calorimetry in psoriatic patients treated with drugs. Journal of Thermal Analysis and Calorimetry 116:2, pages 557-562.
Crossref
Arif Aslam & Christopher EM Griffiths. (2014) Drug therapies in dermatology. Clinical Medicine 14:1, pages 47-53.
Crossref
Jung-Tai Liu. (2014) Psoriatic arthritis: Epidemiology, diagnosis, and treatment. World Journal of Orthopedics 5:4, pages 537.
Crossref